These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36937821)

  • 41. Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients.
    Simon D; Kleyer A; Bayat S; Tascilar K; Kampylafka E; Meinderink T; Schuster L; Petrov R; Liphardt AM; Rech J; Schett G; Hueber AJ
    Arthritis Res Ther; 2019 Jul; 21(1):162. PubMed ID: 31269973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A retrospective observational study of glucosamine sulfate in addition to conventional therapy in hand osteoarthritis patients compared to conventional treatment alone.
    Tenti S; Giordano N; Mondanelli N; Giannotti S; Maheu E; Fioravanti A
    Aging Clin Exp Res; 2020 Jun; 32(6):1161-1172. PubMed ID: 31429006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA).
    Singh JA; Tornberg H; Goodman SM
    Joint Bone Spine; 2020 Jul; 87(4):307-313. PubMed ID: 32147565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Domains of quality of life affecting elderly patients with hand osteoarthritis: a qualitative study in the Asian perspective.
    Thumboo J; Wu L; Leung YY
    Int J Rheum Dis; 2017 Sep; 20(9):1105-1119. PubMed ID: 26990791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis.
    Doan QV; Chiou CF; Dubois RW
    J Manag Care Pharm; 2006 Sep; 12(7):555-69. PubMed ID: 16981801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Biologics in Rheumatoid Arthritis: A Narrative Review.
    Patel JP; Konanur Srinivasa NK; Gande A; Anusha M; Dar H; Baji DB
    Cureus; 2023 Jan; 15(1):e33293. PubMed ID: 36606106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic rheumatic diseases: From biological agents to small molecules.
    Sarzi-Puttini P; Ceribelli A; Marotto D; Batticciotto A; Atzeni F
    Autoimmun Rev; 2019 Jun; 18(6):583-592. PubMed ID: 30959214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health status and perception of pain: a comparative study between female patients with hand osteoarthritis and rheumatoid arthritis.
    Slatkowsky-Christensen B; Mowinckel P; Kvien TK
    Scand J Rheumatol; 2009; 38(5):342-8. PubMed ID: 19585382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis.
    Lechtenboehmer CA; Burkard T; Reichenbach S; Walker UA; Burden AM; Hügle T
    Arthritis Res Ther; 2021 Oct; 23(1):267. PubMed ID: 34702319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A current review of molecular mechanisms regarding osteoarthritis and pain.
    Lee AS; Ellman MB; Yan D; Kroin JS; Cole BJ; van Wijnen AJ; Im HJ
    Gene; 2013 Sep; 527(2):440-7. PubMed ID: 23830938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies.
    Lalor AF; Brooker JE; Rozbroj T; Whittle SL; Hill CL; Rowett D; Buchbinder R; O'Connor DA
    Semin Arthritis Rheum; 2022 Aug; 55():151988. PubMed ID: 35286905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars.
    Woodworth TG; den Broeder AA
    Best Pract Res Clin Rheumatol; 2015; 29(4-5):543-9. PubMed ID: 26697765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring the Involvement of NLRP3 and IL-1
    Fioravanti A; Tenti S; McAllister M; Chemaly M; Eakin A; McLaughlin J; Bjourson AJ; Frati E; McGilligan V; Cheleschi S; Gibson DS
    Mediators Inflamm; 2019; 2019():2363460. PubMed ID: 30983879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An update on disease modifying antirheumatic drugs.
    Joshi P; Dhaneshwar SS
    Inflamm Allergy Drug Targets; 2014; 13(4):249-61. PubMed ID: 25244345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-Effectiveness of Treatment Strategies with Biologics in Accordance with Treatment Guidelines for Ankylosing Spondylitis: A Patient-Level Model.
    Le QA; Kang JH; Lee S; Delevry D
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1219-1231. PubMed ID: 32996395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence.
    Mouyis M; Flint JD; Giles IP
    Semin Arthritis Rheum; 2019 Apr; 48(5):911-920. PubMed ID: 30220537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D).
    Das AK; Kalra S; Tiwaskar M; Bajaj S; Seshadri K; Chowdhury S; Sahay R; Indurkar S; Unnikrishnan AG; Phadke U; Pareek A; Purkait I
    J Assoc Physicians India; 2019 Dec; 67(12):65-74. PubMed ID: 31801334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The disability associated with hand osteoarthritis is substantial in a cohort of post-menopausal women: the QUALYOR study.
    Auroux M; Merle B; Fontanges E; Duvert F; Lespessailles E; Chapurlat R
    Osteoarthritis Cartilage; 2022 Nov; 30(11):1526-1535. PubMed ID: 35995128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of tumor necrosis factor α in rheumatoid arthritis.
    Kulp W; Corzillus M; Greiner W; Pientka L; Siebert U; von der Schulenburg JM; Wasem J
    GMS Health Technol Assess; 2005 Dec; 1():Doc12. PubMed ID: 21289933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.